| Oct 31 |
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
|
| Oct 24 |
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma
|
| Oct 10 |
Bionano Genomics Shares Fall After Lowered Q3 Revenue Guidance
|
| Oct 10 |
Bionano Genomics cuts Q3 revenue view to $6.5M-$6.8M from $7.9M-$8.9M
|
| Oct 10 |
Bionano Announces Preliminary 3Q 2024 Revenues and Cash
|
| Oct 3 |
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024
|
| Sep 10 |
BTIG downgrades Bionano to Neutral after fourth workforce reduction
|
| Sep 4 |
Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
|
| Aug 13 |
Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)
|
| Aug 13 |
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why
|
